| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |